戻る Agenda
Panel Discussion
Session Chair(s)
Fusashi Ishikawa, PHD, MSC
Associate Biopharmaceutics Research Fellow, Formulation R&D Laboratories
Sumitomo Dainippon Pharma Co., Ltd., Japan
Noriko Katori, PHD
Division of Drugs
National Institute of Health Sciences, Japan
Speaker(s)
Hiroyasu Ogata, PHD
Meiji Pharmaceutical University, Japan
Professor Emeritus
Chikako Yomota
National Institute of Health Sciences, Japan
Invited Researcher
Lawrence Yu, PHD
FDA, United States
Director, Office of New Drug Products, OPQ, CDER
Susana Almeida
Inflamax Research Inc., Portugal
Senior Director of European Operations
Yutaka Takahashi
Astellas Pharma Inc., Japan
Senior Manager, Pharmaceutical Planning & Control
Shinya Suzuki
Sumitomo Dainippon Pharma Co., Ltd., Japan
Director, Planning & Administration Group,Technology Research & Development Mgmt
Noriyuki Muranushi, PHD
Shionogi & Co., Ltd., Japan
Associate Director, Formulation R&D Center, CMC R&D Division
Hiroko Shibata
National Institute of Health Sciences, Japan
Senior Researcher, Division of Drugs